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POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) AND ITS DNA-BINDING 
CHARACTERISTICS 
 
The poly(ADP-ribose) polymerase (PARP) family is evolutionarily diverse, 
containing 18 different protein members. Roles played by PARP1 in the cell 
appear to be significant in establishing cellular complexity, as a correlation exists 
between higher eukaryotes and prevalence of PARP family members.  Each 
member of the PARP family contains a conserved catalytic domain, which upon 
activation cleaves molecules of NAD+ to form polymers of ADP-ribose, with the 
release of nicotinamide. Poly(ADP-ribosyl)ation reactions carried out by PARP 
family members have been found to function in regulation of cellular systems 
including DNA-damage repair, transcription, mitotic spindle formation, telomere 
maintenance and cell-death signaling.  
The most well established member of the PARP family is poly(ADP-
ribose) polymerase 1 or PARP1. PARP1 has been found to associate with an 
assortment of DNA structures within the cell. Despite being able to complex with 
any DNA present in the cell, PARP1 displays a propensity to interact with sites of 
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DNA-damage. As such, PARP1 has been found to play a major role in initiation 
of DNA-damage repair.  Through its catalytic activity PARP1 recruits additional 
DNA-damage repair machinery and promotes exposure of the site of damage 
through chromatin relaxation. Due to its ability to regulate chromatin structure, 
PARP1 has also been frequently connected with transcription regulation. 
Variable regulation of transcription by PARP1 has been observed. Catalytically 
inactive PARP1 can function in a similar fashion as the protein H1 to condense 
chromatin. Alternatively, active PARP1 functions to relax chromatin surrounding 
promoter regions and recruit transcription machinery. 
PARP1 activity appears to be primarily regulated through its association 
with DNA. Little is known regarding PARP1-DNA-binding affinity. Here I present a 
high-throughput in-solution FRET-based assay that I utilize to better characterize 
PARP1’s interaction with sites of DNA-damage. In addition, the PARP1-
nucleosome complex was analyzed utilizing the same FRET-based assay. 
Discrepancies found between PARP1 binding affinities to various DNA-damage 
and mononucleosome constructs provide insight into a potential variable mode of 
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Poly(ADP-Ribose) polymerase 1 (PARP1) is the second most abundant protein 
in eukaryotes. PARP1 plays a role in many cellular processes including DNA-
damage repair, gene regulation, chromatin modification and dynamics, mitotic 
spindle formation, and cell-death signaling [1, 2]. In addition, PARP1 has been a 
target in the field of medicine due to its links to cardiovascular disease, ischemic 
stroke, septic shock, diabetes, inflammation control, and cancer treatment [3, 4]. 
 
PARP1 contains an N-terminal DNA-binding domain followed by a BRCT domain 
and a C-terminal catalytic domain [1]. PARP1’s catalytic domain catalyzes the 
production of nicotinamide and polymers of ADP-ribose (PAR) from NAD+ and 
ATP substrates [1]. PARP1’s catalytic activity is linked to the majority of its 
functions within the cell. It has been shown that PARP1 catalytic activation is 
dependent upon recognition and binding of DNA [2, 5]. To date, no substantial 





I have developed a high-throughput FRET-based binding assay in order to 
quantitate the interaction of PARP1 with DNA. I used DNA constructs that mimic 
typical sites of damage within the cell, as well as constructs deviating from the 
traditional double helical structure. Additionally, the interaction of PARP1 with the 
nucleosome was assessed. Our data suggest that PARP1 uses different binding 
modes to interact with the different DNA constructs and with nucleosomes. This 
provides insight into the multifaceted binding capabilities exhibited by PARP1. 
Furthermore, the observed discrepancies are analogous with the diverse roles of 
PARP1 within the cell. This correlation may help elucidate a more global 

















Poly (ADP-Ribose) Polymerase 1 
The large PARP family has 18 protein members expressed from different genes. 
Each member of the PARP family contains a conserved PARP catalytic domain 
[1]. PARP1 and PARP2 exist as the only known members with an immediate role 
in DNA-damage signaling and repair [1]. The best-characterized PARP family 
member is PARP1.  
 
PARP1 is a 1014-residue protein containing a flexible hinge region that acts to 
connect the DNA-binding region and auto-modification domain of PARP1 to the 
conserved PARP family catalytic domain. PARP1’s DNA-binding domain consists 
of two homologous Zn finger motifs and a Zn ribbon domain [1, 6]. Adjacent to 
the Zn finger motifs is a BRCT domain common to proteins associated with DNA-
damage repair.  Connected to the PARP1 DNA-binding domain by a flexible 
hinge region exists a poorly classified WGR domain, followed by the PARP 








Figure 1- PARP1 contains two Zn fingers comprised within its DNA 
binding domain that are connected via a flexible hinge region to the 
PARP catalytic domain. (A) PARP1 is composed of three zinc-containing 
domains (two Zn fingers and a Zn ribbon fold) and a BRCT domain connected 
by a flexible hinge region to its WGR domain and a catalytic domain 
conserved throughout the PARP family. (B) A recent crystal structure displays 
interactions made by the two Zn finger motifs of PARP1 with blunt-ended DNA 
through a hydrophobic base stacking loop and a charged phosphate 
backbone grip region. Crystal structures of Zn fingers in complex with DNA 
adapted from Langelier et al., J Biol Chem, 2011. 286(12): p. 10690-10701.   
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The catalytic domain present at PARP1’s C-terminus converts molecules of 
NAD+ to polymers of ADP-ribose in reactions targeting assorted cellular proteins, 
in addition to auto-modification of its own BRCT domain [1, 2, 7].  Poly(ADP-
ribos)ylation (PARylation) of protein targets, such as the DNA-damage repair 
protein XRCC1 and histones H2A and H1, act to initiate and regulate various 
cellular pathways. In addition, PARP1 has been shown to function via 
heterodimerization with proteins through its BRCT domain [1, 7].   
  
Catalytic activity of PARP1 is activated upon binding to DNA containing blunt 
ends, internal nicks and overhang regions [8]. Recent crystallography and NMR 
data indicate that PARP1 interaction with blunt-ended DNA is mediated through 
hydrophobic loops contained on each Zn finger [9]. Structural data also indicates 
that electrostatic contacts made by charged residues of the Zn fingers with the 
DNA phosphodiester backbone act in stabilizing the PARP1-DNA complex 
(Figure 1B) [9].  It has been proposed that PARP1 activation is dependent on a 
conformational change across the hinge region induced by the binding of the 
zinc-finger containing domains to sites of DNA-damage [8]. PARP1 activation 
facilitates catalysis of poly (ADP-ribosyl)ation reactions targeted to multiple 






Cellular response to DNA-damage 
Although prevalent in many cellular processes, PARP1 functions primarily in 
DNA-damage repair initiation and signaling cell-death pathways in the presence 
of widespread DNA-damage. Genetic information manifested as DNA within each 
cell is pivotal to cellular function and replication. As such, the cell spares no 
expense in its response to and repair of DNA-damage. DNA integrity is 
susceptible to frequent attack by a plethora of agents that are generated by 
routine cellular metabolism and environmental factors. DNA malformations are 
induced by improper incorporation of dNTPs during DNA replication, DNA 
deamination, depurination and alkylation, as well as by exposure to reactive 
oxygen species (ROS). Environmental damage is also prevalent as the cell is 
subjected to external factors such as ionizing radiation (IR) and UV light [7, 13-
15]. 
 
Single-strand breaks (SSBs) and double-strand breaks (DSBs) are encountered 
regularly in the cell. Numerous cellular pathways are devoted to the repair of 
such DNA-damage. Repair pathways dealing with SSBs include mismatch repair 
(MMR), which corrects improperly incorporated base pairs, and base-exclusion 
repair (BER), which targets chemically modified nucleotides [7]. Nucleotide-
excision repair (NER), which identifies and removes regions exhibiting extensive  
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damage, acts through DSB intermediates. Lesions in the form of DSBs are 
repaired through non-homologous end joining (NHEJ) and homologous 
recombination (HR) [7].  
 
The complexities of DNA-damage repair are further compounded by the range of 
proteins involved in each pathway. Tight regulation of repair pathways is 
essential to ensure cellular competence. In order to prevent DNA-damage 
proliferation, a close relationship is held between DNA-damage repair and cell-
death [1, 13, 15]. This relationship ensures removal of any cell species exhibiting 
exhaustive DNA-damage or faulty repair mechanisms. Members of the 
phosphoinositide-3-kinase-related protein kinase (PIKK) family (ATM, ATR and 
DNA-PK) and the PARP family are largely responsible for recognition of sites of 
DNA-damage and signaling of either repair pathways or cellular apoptosis and 
senescence through intermediates like p53 [1, 13, 15].  
  
PARP1-dependent DNA-damage repair pathways 
 
Base-Exclusion Repair Pathway  
Although linked to multiple SSB repair pathways, PARP1 is most widely 
associated with base-exclusion repair (BER), an important pathway in the 
correction DNA base damage. BER targets and repairs damaged genomic DNA 
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through a SSB intermediate. Two types of BER exist within the cell, short-patch 
and long-patch BER [7]. In short-patch repair a DNA glycosylase recognizes the 
site of damage and converts it to an apurinic/apyrimidinic (AP) site. 
Apurinic/apyrimidinic endonuclease 1 (APE1) then recognizes the newly formed 
AP site and cleaves the phosphodiester bond, yielding a nick in the DNA with a 5’ 
deoxyribose phosphate and a 3’ hydroxyl group. The 5’-deoxyribose phosphate 
is then removed and the correct Watson-Crick base pair is inserted by DNA 
polymerase β (Pol β). Upon proper insertion of the correct nucleotide, DNA 
Ligase III seals the nick [7].  
 
Long-patch repair occurs when the 5’-deoxyribose phosphate has undergone 
oxidation or reduction. If an oxidized or reduced 5’-deoxyribose phosphate is 
present, long-patch repair acts to displace the 5’-deoxyribose phosphate via a 5’-
flap structure. This pathway involves additional factors, including flap 
endonuclease 1 (FEN1) and proliferating cell nuclear antigen (PCNA) [7].  
 
PARP1 and SSB repair 
PARP1’s role in SSB repair has been the subject of widespread investigation. In 
the most widely accepted model for PARP1’s involvement in SSB repair, PARP1 
recognizes nicked regions of DNA, presumably following APE1 cleavage of AP 
sites in BER [1, 2]. Upon binding, PARP1 is activated, catalyzing a series of 
PARylation reactions using NAD+ as its substrate. Active PARP1 functions to 
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increase accessibility to the site of damage through relaxation of the surrounding 
chromatin. PARP1 achieves chromatin decondensation through PARylation 
reactions targeting nearby H2A and H1 histones, promoting relaxation of 
chromatin surrounding the site of damage (Figure 2B). In addition, PARP1 
targets itself in an auto-PARylation reaction, creating a large PAR network 
stemming from its own BRCT domain. Through this mechanism PARP1 recruits 
additional BER factors including XRCC1, DNA ligase III, and Pol β to the site of 
damage [1, 2, 16]. Recruitment occurs through PAR modification of the factor, 
interaction with the produced branched PAR moiety or via protein-protein 
interactions with the PARP1 BRCT domain (Figure 2B) [1, 2]. Once a threshold 
of auto-PARylation is met, PARP1 will dissociate from the DNA allowing the 
recruited factors to complete the repair process through nucleotide insertion and 
DNA-strand ligation. Chromatin compaction then occurs as a PAR-hydrolyzing 
enzyme, poly(ADP-ribose) glycohydrolase (PARG), cleaves the remaining PAR 
network surrounding the site of damage (Figure 2C) [1].  
 
Additional models of PARP1 SSB-repair association are different in the mode 
and chronology of PARP1 recruitment to sites of damage. One such model 
depicts PARP1 as a negative regulator of long-patch repair. Sukhavnova et al. 
demonstrated a correlation between long-patch repair inhibition and PARP1 
localization to DNA, while observing no such inhibition of short-patch repair by 
PARP1. They also noted that auto-PARylation of PARP1 significantly reduced 





Figure 2 - A model of PARP1-mediated chromatin loosening at sites of 
DNA damage. (A) PARP1 (green) interacts with condensed chromatin when 
catalytically inactive. (B) Upon recognition of DNA damage the PARP1 
enzymatic domain catalyzes poly(ADP-ribosyl)ation (red) of core histones (blue) 
proximal to the site of damage, generating a relaxed chromatin structure. 
PARylation reactions catalyzed by PARP1 recruit DNA-damage repair factors to 
the now exposed site of damage. (C) Upon completion of DNA-damage repair, 
auto-inactivation of PARP1 through self-modification and the degradation of 
PAR molecules by PARG return the chromatin to its condensed state (C). 







Recently, the Helleday group observed a lack of SSB accumulation following 
exposure to an alkylating agent in cells depleted of PARP1 using siRNA. The 
introduction of alkylating agent induced DNA-damage sites similar to what is 
targeted in BER. Failure to generate an increase in SSB’s in PARP1 depleted 
cells led the Helleday group to conclude that PARP1 plays no direct role in BER. 
They propose an alternative function in which PARP1 acts in a repair 
enhancement fashion [18]. The Helleday group suggests that past literature is 
likely skewed by the use of PARP1 inhibitors in control groups. PARP1 inhibitors 
obstruct any catalytic activity of PARP1, but in the process also trap PARP1 in 
complex with DNA. This trapping of PARP1 to the site of damage may impair 
additional components of BER from recognizing the site, leading to a lack of 
DNA-repair resolution [18].     
 
Non-Homologous End Joining 
Non-homologous end joining (NHEJ) is a major DNA-damage repair pathway 
responsible for the repair of DSB’s in cellular DNA. NHEJ maintains activity 
throughout the cell cycle and is important for V(D)J recombination and for repair 
of endogenously and exogenously induced DSBs [19]. NHEJ corrects DSBs 
through ligation of the two cleaved DNA ends. This process is initiated by 
Ku70/Ku80 alignment of severed DNA ends. Ku70/Ku80 then recruits DNA-PK 
and activates its kinase function. DNA-PK in association with Artemis and other  
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processing proteins then prepare the DNA ends for ligation through the addition 
of a 5’-phosphate group. At this point XRCC4 in complex with DNA ligase IV, join 
the broken strands together [20].   
 
PARP1 competes with Ku70/Ku80 for the site of damage, potentially signaling an 
alternative-NHEJ mechanism through recruitment of the MRN complex [21]. This 
alternative-NHEJ mechanism is prevalent when NHEJ factors are absent or 
malfunctioning [22].  
 
Homologous Recombination  
Homologous recombination (HR) is the second of the two PARP1-associated 
DSB repair pathways. HR conservatively and accurately repairs DSBs though 
utilization of the damaged sequence’s sister chromatid [20]. As such, HR 
functions in S phase and G2 phase of the cell cycle [20, 23]. HR functions by first 
processing portions of each DNA end, producing 3’-ssDNA overhangs. Rad51 
will then match homologous DNA from the sister chromatid to the repair site. 
Strand exchange will then occur via Holliday junction formation [20].  
 
PARP1 maintains a dual relationship with HR. DNA-replication forks pause when 
encountering SSBs. The SSB is then cleaved to a DSB and repaired by HR 
before the replication fork can restart [1, 2, 24]. PARP1’s role in initiation of SSB-
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repair pathways leads to the repair of DNA-damage prior to their recognition by 
replication forks and subsequent propagation to DSBs. Thus, PARP1 indirectly 
inhibits the HR pathway through initiation of SSB repair. 
 
Paradoxically, PARP1 also has been linked to HR initiation at stalled replication 
forks. Repair of DSBs present at replication forks is dependent on PARP1 in 
complex with MRN and ATM [25]. The MRN/PARP1/ATM complex is required for 
the DNA strand resection involved in HR. Once the DSB is repaired the 
replication machinery will reinitiate and continue beyond the newly repaired DNA 
[25].   
 
Chromatin dynamics and gene regulation 
Approximately two meters of DNA exist within an 8 µm cell nucleus. This 
remarkable feat is accomplished through the packaging of genomic DNA into 
protein-DNA complexes known as chromatin. In its most basic form, chromatin 
exists in a ‘beads on a string’ formation in which the fundamental units of 
chromatin, nucleosomes, are separated by a given amount of linker DNA. This 
beads on a string structure becomes further compacted into a 30-nm chromatin 
fiber, which forms its final tertiary structure through additional intermolecular 




The nucleosome is composed of 147 bp of DNA wrapped 1.65 times around a 
protein histone octamer [26]. The histone octamer is composed of a H3-H4 
histone tetramer and two H2B-H2A dimers [27]. An additional histone, H1, is also 
associated with the nucleosome. H1 promotes compaction through interaction 
with linker DNA and the nucleosome dyad [28]. Each core histone is composed 
of an α-helical folded region and a highly disordered N-terminal ‘tail’ region. The 
ordered fold region of each histone interacts with DNA, while the disordered N-
terminal tails are responsible for interactions between adjacent nucleosomes 
[26]. In addition, modifications of the histone tails play important roles in 
regulation of the dynamic chromatin structure [29].   
 
Regulation of chromatin dynamics is essential for proper gene expression and 
DNA-damage repair. In order for the genetic material to be readily available, 
chromatin structure must be highly dynamic, alternating between a condensed 
and relaxed state. Highly condensed chromatin, termed heterochromatin, is 
inaccessible to transcription and DNA-repair machinery. For transcription and 
DNA-damage repair machinery to gain access to genomic DNA, chromatin must 
convert to its more loosely packed state, euchromatin. Chromatin dynamics are 
regulated through histone-tail modification, chromatin remodeling complexes, 





PARP1 and gene expression 
PARP1 interacts with nucleosomes in a manner similar to H1. Although the exact 
mechanism of each is a subject of speculation, both serve to regulate function in 
determining nucleosome spacing and chromatin dynamics [30, 31]. H1 and 
PARP1 compete for binding to nucleosomes, indicating that both display similar 
affinities for regions in close proximity along the nucleosome [32]. Interestingly, a 
trend is observed at transcribed promoters, in which a decrease in H1 presence 
is observed concomitant with an increase in PARP1 localization [32].  
 
PARP1 displays contrasting roles in chromatin dynamics. Inactive PARP1 
associates with chromatin in the nucleus when experiments are performed under 
steady-state conditions [31, 33]. In cells in which PARP1 has been knocked out, 
a significant change in overall chromatin compaction is observed. Intriguingly, 
despite its global effect on chromatin compaction, PARP1 plays a dual role in 
transcription leading to activation of certain genes while repressing others [34, 
35]. 
 
When catalytically inactive, PARP1 functions to inhibit gene expression through 
compaction of chromatin found at gene promoter regions [30]. Inactive PARP1 
also expels the chromatin-compaction protein H1 at various PARP1-stimulated 
genes. Following expulsion of H1 and association of PARP1 to chromatin 
surrounding the gene promoter, gene expression is stimulated as PARP1 
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becomes activated. PARylation of histone targets by PARP1 allows transcription 
machinery to gain access to the promoter due to decondensation of surrounding 
chromatin. It is possible that inactive PARP1 expels H1 and associates with 
genes in a poised state, maintaining compaction of promoter chromatin until 
signaled to activate and promote expression. It is important to note that at genes 
in which the presence of PARP1 is tied to repression, no pattern of H1 and 
PARP1 colocalization are observed [36]. Additional effects of PARP1 on 
transcription regulation have been tied to PARP1 interactions with transcription 
machinery [16, 32, 35, 38, 44].  
 
In addition to direct histone PARylation, PARP1 catalytic activity has been tied to 
histone acetylation and H4 Lys4 trimethylation (H3K4me3) [35]. The mode of 
PARP1 regulated gene expression remains unclear, but multiple mechanisms 
have been proposed. The most simplistic mechanism of transcriptional regulation 
is through PARP1’s ability to PARylate core histones. PAR carries a large 
negative charge and as such is likely to promote relaxation of chromatin due to 
PAR-DNA charge repulsion [37]. Additionally, PARP1 may control transcription of 
certain genes through its recruitment of the transcriptional machinery. A 
correlation between PARP1 and recruitment of TBP, TFIIB and Pol II at given 
promoters has been observed [16, 32]. PARP1 has also been found to interact 
with proteins of the ERK transcription regulation pathway. Active PARP1 
interacts directly with ERK2, which increases ERK2 phosphorylation of ERK1. 
Phosphorylated ERK2 promotes an increase of histone acetylation at the target 
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promoter, up-regulating gene expression [38]. Furthermore, PARP1 catalytic 
activity has been linked to H3K4me3. Upon PARP1 knockdown, the Kraus group 
observed a decrease in H3 methylation at PARP1-activated genes and an 
increase in methylation at PARP1-inhibited genes, with no effect on PARP1 
independent genes [35]. They propose a mechanism in which PARP1 PARylates 
and inhibits promoter binding of KDM5B, a lysine-specific histone demethylase.    
 
It is clearly evident that PARP1 plays a multifaceted role in chromatin dynamics, 
in which it exhibits positive and negative gene regulation function. Gene 
expression and repression by catalytically active and inactive PARP1, 
respectively, suggests a dual function that is dependent upon PARP1 interaction 
with particular genes, or chromatin as a whole. PARP1 may contribute to 
indiscriminate nucleosome spacing and chromatin condensation in its inactive 
form, while regulating target genes via its catalytic activity upon activation.  
 
PARP1’s additional roles in the cell 
PARP1 promotes cell-death when extensive DNA-damage is present (Figure 3). 
Upon DNA-damage recognition, PARP1 signals formation of a Rad9, Rad1, 
Hus1 complex [13]. This complex is then activated upon Rad17 stimulation and 
produces a cascade of signals involving the serine/threonine-protein kinases 





Figure 3- PARP1 activation at sites of DNA-damage signals repair 
mechanisms or death pathways. In replicating cells, limited DNA damage 
leads to PARP1 activation and signaling of repair pathways. During p53 
signaling of apoptosis, caspases cleave PARP1, inhibiting signaling of repair 
pathways as the cell proceeds towards cell death. In cells exhibiting excessive 
DNA damage, overactivation of PARP1 leads to NAD+ depletion, along with 
translocation of Apoptosis-Inducing Factor (AIF) to the nucleus.   
19 
 
check-points including histone H2AX, CHK2 and p53. Once signaled, the cell-
cycle check-points induce cell-cycle arrest. Subsequent death or rejuvenation 
depends on the cell’s ability to successfully repair the site of damage [1, 13].  
 
PARP1 is also involved in cell-death when stimulated by excessive ROS [13, 39]. 
PARylation by PARP1 consumes NAD+ and ATP as substrates. Cellular 
depletion of NAD+ and ATP due to highly active PARP1 can promote cell-death 
by necrosis (Figure 3). In response to excess ROS, PARP1 may also trigger 
apoptosis through interaction with apoptosis-inducing factor (AIF) [39]. In this 
poorly understood mechanism, PARP1 activation can trigger the release of AIF 
from mitochondria. AIF will then target to the nucleus where it induces chromatin 
condensation and DNA fragmentation [39]. 
 
Other PARP family members play important roles in maintaining genome 
stability. For example, PARP family members Tankyrase 1 and Tankyrase 2 play 
major roles in maintaining telomere integrity [40]. Telomere maintenance is 
essential for cell survival, as critical shortening of telomeres leads to cell 
senescence and death [40]. Additionally, telomeres exist as the DNA termini of 
chromosomes, and are logical targets of PARP1 interaction, as PARP1 is known 
to interact with DNA ends. In mice engineered for PARP1 knockdown, telomere 
shortening is observed [41]. In addition, when uncapped telomeres are induced 
by the G4 ligand RHPS4, PARP1 activation and localization to the uncapped 
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telomeres occurs [41, 42]. It has been shown that PAR units produced by PARP1 
at uncapped telomeres are associated with telomere-repeat binding factor I 
(TRF1). PARP1 has also been found to interact directly with TRF2 and PARylate 
telomere-associated protein POT1 [42, 43]. PARP1’s telomere-associated 
functions are thought to assist in telomere repair and maintenance.  
 
PARP1, along with five other members of the PARP family, including Tankyrase 
1 and 2, are also associated with various components of the mitotic apparatus 
(PARP2, PARP3, VPARP, tankyrase1, and tankyase2) [44]. PARP1 has been 
shown to associate with mitotic centromeres, centrosomes, and mitotic spindles. 
Although its function is poorly understood, regulation of PARylation appears 
pivotal to control of mitotic functions. One proposed function of PAR molecules is 
in assembly and orientation of bipolar spindles [44]. It has been suggested that 
PARylation may act as a signaling mechanism in regulation of mitotic spindle 
proteins, or in the formation of a matrix that is utilized in spindle assembly [44]. 
Involvement of active and inactive PARP1 with additional cellular functions and 
pathways continues to be investigated.  
 
Förster Resonance Energy Transfer (FRET) 
In 1948 Theodore Förster refined a theory outlining dipole-dipole energy transfer 
that was originally proposed by Jean-Baptiste Perrin in 1927 [45-47]. Perrin’s 
dipole-dipole energy transfer theory was presented as a possible explanation of 
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depolarization of fluorescence in dye solutions at high concentrations [47]. Perrin 
hypothesized that energy transfer between an excited molecule and a nearby 
molecule could occur without needing physical contact and without the emission 
and absorption of a photon. This energy transfer would occur through interaction 
of oscillating dipoles from two molecules in close proximity [47]. Over 20 years 
following Perrin’s initial hypothesis, Förster published his first paper on Förster 
resonance energy transfer, or FRET, in which he expanded upon Perrin’s 
preliminary findings to produce the first correct theoretical description of the 
FRET process [47]. In this paper, Förster developed a theory in which one could 
quantitate rate and efficiency of energy transfer between donor and acceptor 
molecules [46, 47].  
 
E. R. Blout and Lubert Stryer went on to confirm Förster’s theories on FRET and 
apply them at the molecular level as a ‘spectroscopic ruler’ [48, 49]. This 
application is possible due to Förster’s theory of efficiency of energy transfer (E) 
as governed by the equation: 
 
 
where r is the distance between the donor and acceptor and Ro is the distance at 
which the efficiency of transfer is 50% [46]. Intensity of emission by the acceptor 
molecule can be applied to the characterization of structure and dynamics of 
macromolecular interactions. Additionally, FRET is highly sensitive as it is able to 
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monitor systems ranging from high micromolar to low nanomolar concentrations 
[50]. FRET is presently utilized in many experimental systems, ranging from 
analysis of in vivo protein-protein interactions to in vitro quantification of protein-
DNA affinities [50].  
 
Caution must be imposed when utilizing FRET in binding experiments to ensure 
data validity due to the nature of data collection. FRET emission spectra 
following donor-acceptor energy transfer also contains basal level contribution 
from non-FRET invoked donor and acceptor emission. Energy transfer from 
donor to acceptor molecules is not a 100% efficient process, leaving a degree of 
donor emission that contributes to the overall FRET signal. Additionally, acceptor 
molecules are also excited directly by wavelengths that are used to excite donor 
molecules. This may also generate contribution to the overall FRET spectra 
through acceptor emission independent of the FRET mechanism. As a result, 
experimental methods incorporating FRET must carefully account for any donor 
and acceptor contribution through signal normalization. Adequate normalization 
is performed through controls unique to each FRET reaction system.  
 
When employed correctly, FRET can be a powerful tool, as I demonstrate here 
with its use in PARP1-DNA-binding studies. To determine PARP1 affinities to 
DNA, a donor fluorophore was added to the PARP1 protein and an acceptor 
fluorophore was added its DNA substrate. Affinities were then determined after 
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imaging titration reactions performed in a 384-well microplate. The sensitivity 
provided by FRET allowed for detailed analysis of PARP1’s binding affinity to 
various DNA substrates. Additionally, due to the versatility of the FRET system 
developed, we were able to display that full-length PARP1 binds with higher 
affinity than a Parp1-486 truncation construct to DNA-damage substrates and 
nucleosomes. Results obtained by FRET allow us to propose a mechanism in 
which PARP1 activity may be driven by differences in its binding affinity to the 


















Cloning, expression and purification of Parp1-486 
The first 486 residues of PARP1 plus an N-terminal 6x histidine tag were cloned 
into a pET28a vector system (Novagen). Parp1-486 was expressed in E. coli BL43 
cells after cells grew to an absorbance of 0.6-0.8. Expression proceeded for 5 hr 
at 30⁰ C. 6 L of cells were resuspended in 100 mL of lysis buffer (300 mM NaCl, 
25 mM Tris pH 7.0) containing a single tablet of protease inhibitor cocktail 
(Roche). Following cell lysis via sonication, the protein was bound to a Ni-NTA 
fast flow column (Qiagen). Ni resin with bound protein was washed three times 
with 50 mL of resuspension buffer (200mM NaCl, 25 mM Tris pH 7.0, 25 mM 
imidazole). The protein was eluted from the Ni column using 300 mM imidazole, 
200 mM NaCl, and 25 mM Tris pH 7.0. Protein was further purified using 
Hightrap-SP cation-exchange column (GE Healthcare), followed by S75 size-
exclusion chromatography.   
 
Fluorescent labeling of Parp1-486 
Purified full-length PARP1, Parp1-486 and Parp487-1014 were fluorescently labeled 
on their intrinsic cysteine residues. 10 mM Alexa-488 fluorophore (Invitrogen) in 
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DMSO was added to protein in 300mM NaCl, 25mM Tris pH 7.5 in equimolar 
amounts three times over three hours and allowed to mix overnight to ensure a 
high efficiency of labeling. Free fluorophore in-solution was separated using a 
Hightrap-Heparin HP cation-exchange column (GE Healthcare).  
 
DNA oligomer preparation 
Blunt-ended, nicked, gap, and overhang DNA all containing the template 
sequence 5’- ATC AGA TAG CAT CTG TGC GGC CGC TTA GGG -3’ and with 
labeled sequences containing a 5’-Cy5 fluorophore were ordered from Integrated 
DNA Technologies (IDT). Blunt-ended DNA reverse sequence was the 
complement of the template sequence. Overhang sequence reverse sequence 
was 5’-ATC AGA CCC TAA GCG GCC GCA CAG ATG CTA-3’ with the first 6bp 
of the reverse and template sequence remaining single stranded upon annealing. 
AATT-insert DNA was identical to the blunt-ended sequence with a 5’-AATT-3’ 
nucleotide substitution of bases 14-17. Nicked and gapped DNA’s were 
generated through deletion of a central base pair or introduction of a break in the 
phosphodiester backbone in the reverse sequence. Annealing was carried out 
through 2 min. heating at 95⁰ C of equimolar template and reverse strand, 






Protein-DNA and protein-nucleosome complexes were assayed for stoichiometry 
and affinity analysis using 5% native acrylamide gels. Gels were run in 50 mM 
Tris-Borate buffer at pH 8.8. Gels were visualized without stain under UV-light 
prior to staining with ethidium bromide and Coomasie blue stain.  
  
FRET assay 
In-solution based FRET assays were done with Alexa488 labeled PARP1 as 
fluorescent donor, and with DNA or nucleosome labeled with Cy5 or Atto647 as 
fluorescent acceptor. DNA was labeled as stated above and nucleosomes were 
labeled at an incorporated E63C mutation located in the H4 histones. Each 
assay depicts a 23-point DNA or nucleosome titration to constant [PARP1] (5-10 
fold below measured Kd); each assay was performed in duplicate. Unless 
otherwise stated, the reaction buffer contained 200mM NaCl, 25mM Tris pH 7.5, 
0.01% CHAPS, 0.01% NP40. Reactions were performed in 384-well microplates 
(Greiner bio-one) treated with 2% 1,6-dichlorooctamethyl-tetrasiloxane (in 98% 
heptane) to reduce non-specific interactions. Reactions were imaged using 






FRET was quantified following excitation of donor molecules (using a 488 nm 
laser) through observation of acceptor emission, using a 670/15 emission band 
filter. In order to account for spectral overlap by donor and acceptor molecules in 
FRET spectra, donor and acceptor controls were implemented. The donor control 
consisted of wells containing donor held at a constant concentration (equal to 
[donor] in FRET reaction wells) in the absence of acceptor. To account for an 
increase in spectral overlap of acceptor throughout the FRET titration series, 
normalization to acceptor signal was carried out using entire titration series of 
acceptor without donor. Donor and acceptor controls were imaged using laser 
and filter settings specific to excitation and emission of donor and acceptor 
fluorophores at 3mm focal length (Donor – 488 nm excitation, 520/20 nm 




Donor and acceptor spectral overlap in the FRET signal was accounted for 
through normalization to percent signal contribution. Percent contribution was 
calculated through comparison of donor or acceptor signal to FRET signal in 
donor only and acceptor only wells. Final plotted values were normalized using 





where FRETc is final corrected FRET signal, FRET is total signal obtained using 
FRET excitation and emission settings, and Dc and Ac are percent contribution 
to overall FRET signal due to donor (D) and acceptor (A). Normalized FRET 
replicate values were averaged and plotted in Prism software using: 
 
 
where Fc is normalized FRET counts and Dc is donor counts. Kd’s were 

















The most studied of the evolutionarily conserved PARP family is poly (ADP-
ribose) polymerase 1 or PARP1. PARP1 plays important roles in DNA-damage 
repair, transcription regulation, mitotic spindle formation, telomere maintenance 
and cell-death signaling. PARP1 is a 1014-residue protein comprised of a DNA-
binding region, BRCT domain, WGR domain and the catalytic domain conserved 
throughout the PARP family. When active, PARP1 catalyzes the conversion of 
NAD+ to polymers of ADP-ribose. Active PARP1 can add ADP-ribose units to 
many cellular proteins, but its major target is itself. Auto poly(ADP-ribosyl)ation 
exhibited by PARP1 functions as a pathway signaling mechanism, as well as a 
form of self-regulation.  
 
PARP1 plays a major role in DNA-damage signaling and as expected has been 
found to associate with sites of DNA-damage such as double-strand breaks 
(DSB) and single-strand breaks (SSB). Analysis of PARP1’s mode of interaction 
with sites of DNA-damage is limited in the literature. In order to better understand 
the PARP1-DNA interaction we have developed a highly sensitive FRET-based 
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assay to procure PARP1’s binding affinity to various DNA constructs. We 
observe a binding preference for DNA constructs displaying similar structural 
characteristics to SSB’s.  
 
The PARP1-nucleosome interaction was also assessed utilizing the same FRET-
based assay. A higher binding affinity to mononucleosomes by full-length PARP1 
than a truncation mutant containing only the DNA-binding domain of PARP1 was 
observed. These results suggest that while the DNA-binding domain of PARP1 is 
necessary and sufficient for PARP1 binding, domains located at the C-terminus 
of PARP1 significantly contribute to the interaction with mononucleosomes.  
 
Introduction 
Proteins interact with DNA in the cell to mediate processes such as transcription 
and DNA-damage repair. Protein-DNA interactions are regulated in order to 
ensure proper cellular function. Regulation is primarily performed through 
catalysts, inhibitors, variable chromatin structure, protein translocation and the 
manner of DNA interaction. Protein-DNA interactions occur in a DNA-specific or 
non-specific manner. Classification and strength of interaction are driven by how 
structural motifs of the protein make contact with DNA. Protein interactions will 
occur with base pairs via the major and minor groove, or with the negatively 
charged phosphodiester backbone. In addition to DNA-sequence specificity,  
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proteins have been shown to display increased affinity to specific DNA structure. 
For example, histones, HMG protein and TATA binding protein (TBP) 
preferentially interact with DNA regions displaying higher flexibility [51-53]. 
 
DNA-binding domains interact electrostatically and/or form hydrogen bonds with 
groups in the phosphodiester backbone or the nucleotides. DNA-binding proteins 
typically contain a helix-turn-helix motif, leucine-zipper coiled-coil, β-ribbon, helix-
loop-helix motif, or Zn-containing domain [54]. Often DNA-associated proteins 
contain multiple DNA-binding domains to enhance DNA-binding capability.  
 
PARP1 associates with DNA to carry out the majority of its cellular functions. 
PARP1 contains a DNA-binding domain N-terminally located to its BRCT, WGR 
and catalytic domains. PARP1’s DNA-binding domain is composed of three Zn-
containing motifs: two Zn-fingers and a Zn ribbon fold consisting of three β-
sheets and two terminal α-helices. Each Zn-containing motif is interconnected by 
loop regions variable within the PARP family, which have been proposed to play 
a role in DNA-substrate specificity [1, 6].  Despite the incorporation of well-
characterized Zn motifs much is still to be determined regarding the means in 




PARP1 is a highly basic protein composed of a combined 193 Arg and Lys 
residues, with a pI of 8.99.  Additionally, a role in DNA-binding has been 
proposed for the associated WGR and catalytic (WGR-Cat) domains located at 
the C-terminus of PARP1 [55]. Although the WGR-Cat region of PARP1 contains 
no known DNA-binding motifs, it is possible its overall positive charge mediates 
an interaction with the negatively charged DNA phosphodiester backbone. It is 
likely that the basic WGR-Cat regions are not involved directly in DNA 
recognition and binding, but rather act to stabilize the primary interaction 
between DNA and the Zn-finger motifs.  
 
None of the Zn-containing motifs in the PARP1 DNA-binding domain have been 
found to exhibit DNA sequence specificity. Alternatively, PARP1 Zn-fingers have 
been shown to associate with archetypical DNA-damage structures, such as 
DNA nicks, overhangs and gaps [1, 2]. In addition, PARP1 has been found to 
recognize DNA with distinct secondary structure such as hairpin loops and DNA 
cruciforms [2].  
 
In most cases, PARP1 activity is induced through DNA-binding, resulting in 
PARylation of target proteins. PARP1 does, however, possess functions 
independent of its catalytic activity that are also dependent on interaction with 
DNA. PARP1 has long been related to the chromatin architectural protein H1. An 
inverse relationship between catalytically active PARP1 and H1 occurs at certain 
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transcriptionally active and repressed gene promoters [32]. At such promoters 
catalytically active PARP1 targets surrounding histones for PARylation, 
promoting chromatin relaxation. Interestingly, catalytically inactive PARP1 has 
also been shown to function in nucleosome compaction [30, 31, 33, 44]. PARP1 
was found to localize to the Drosophila hsp70 promoter. When the hsp70 
promoter was not expressed, PARP1 was localized to surrounding euchromatin 
in an inactive state. Upon induction, ‘puffing’ of the gene promoter was observed 
as a response to a robust increase in PAR at the promoter, indicating chromatin 
relaxation upon PARP1 activation [33]. Furthermore, atomic force microscopy 
(AFM) studies by the Kraus group demonstrated compaction of nucleosome 
arrays in the absence of NAD+, the PARP1 substrate. Compaction of arrays was 
shown to be dependent on the presence of PARP1 constructs containing both 
the DNA-binding region and catalytic domain [30].  
 
PARP1 is involved in many processes that are essential to cellular viability. Its 
roles in DNA-damage repair and genome stability have been widely researched, 
yet a steadfast mechanism has yet to be devised. The mode of regulation is a 
major missing piece to the PARP1 puzzle. Affinities generated using a developed 
FRET binding assay display a preference by PARP1 in binding to DNA models 
that have increased accessibility to core nucleotides. We also observe in binding 
affinity and stoichiometry experiments that PARP1 strength of interaction with 
mononucleosomes is dependent on linker-arm DNA length. Additionally, we 
observe that full-length PARP1 binds much tighter to both DNA substrates than a 
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truncated Parp1-486 protein. Interestingly, the increased affinity in which full-length 
PARP1 binds as compared to Parp1-486 is variable between binding to DNA 
constructs and mononucleosomes. These results indicate a possible means in 
which PARP1 regulates its function through variable binding affinities to DNA and 
nucleosome substrates.      
 
Development of a high-throughput binding assay 
Full-length PARP1 is highly toxic when expressed in bacterial cell lines. Due to 
this, a version of PARP1 that only contains the N-terminal half (Zn1, Zn2, Zn3 
and BRCT auto-modification domain: residues 1-486) of PARP1 was produced. 
The Parp1-486 construct is robustly expressed in E. coli after plasmid 
transformation, and purified through a straightforward method using Ni resin, ion-
exchange, and size-exclusion chromatography. Previous experiments in our lab 
showed that Parp1-486’s affinity for 30 bp blunt-ended, nicked, and 3’-overhang 
DNA’s was in the range of 70-300 nM [8]. The characterization of Parp1-486 
dissociation constants (Kd’s) to these DNA constructs was determined using 
fluorescent quenching of labeled DNA’s using a Perkin-Elmer Victor 3V plate 
reader. Efficiency of the fluorescent quenching technique was limited due to the 
capabilities of the plate reader instrument, as well as complications with non-




Much of my research has been devoted to the development of a high-throughput 
assay capable of measuring the thermodynamics of PARP1-DNA interactions in 
an efficient manner that is devoid of the non-specific PARP1 binding variable. 
After much trial and error I settled on an in-solution FRET-based assay utilizing 
Alexa 488 tagged Parp1-486 donor and Cy5 labeled DNA acceptor (Atto 647 was 
substituted for Cy5 in nucleosomes). Non-specific interactions of PARP1 with 
reaction wells are not a problem in this system, as FRET-based measurements 
require limiting donor concentrations (5-fold to 10-fold below the measured Kd). 
As such, any amount of protein lost to non-specific interactions will not bias the 
FRET signal as long as the [donor] is 5-fold to 10-fold below the measured Kd.  
 
The fluorescent labeling of Parp1-486 is possible due to a fortunate structural 
characteristic of the truncated protein. Parp1-486 contains 11 cysteine residues, 10 
of which are incorporated in the three Zn containing motifs (Figure 4). Thus, only 
one cysteine residue (Cys 256) is left accessible to potential Alexa 488 binding. 
Successful preparation of Alexa 488-tagged Parp1-486 was accomplished through 
mixing of protein and fluorophore overnight, followed by removal of free 
fluorophore through purification by a Hightrap-heparin HP cation-exchange 
column. Modification of N-terminally truncated PARP1 (487-1014) is also 
possible through fluorescent labeling of a cysteine residue in the catalytic 






Figure 4- PARP1 contains two potential residues accessible to 
fluorophore modification. Molecular dynamics models as generated by 
Nicholas Clark of full-length PARP1 derived from small angle x-ray scattering 
(SAXS) with the exposed non-zinc coordinating residues shown in red. Images 
are representations of the PARP1-486 construct and WGR-Cat region, each 
independent of the other.  The PARP1-486 construct contains 11 cys residues, 
10 of which are encompassed in the three Zn containing motifs, while the 
WGR-Cat region contains only a single surface exposed cys residue. A single 
non-zinc coordinating cys residue in the DNA binding domain (cys 256)  and 
surface exposed cys residue of the WGR-Cat (cys 845) region act as possible 
targets for fluorescent labeling.  
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becomes labeled at two different sites (Figure 4). Analysis by mass spectrometry 
confirmed respective single and double modifications of the two proteins (data 
not shown).  
 
Each binding curve was obtained by a titration of fluorescently labeled binding 
substrate and a constant concentration of fluorescently labeled PARP1 (Figure 
5). For signal correction purposes, each assay included labeled PARP1 (donor)- 
only wells (in quadruplicate) and a titration (paralleling the FRET titration) of 
labeled substrate (acceptor) only.  Enhancement or quenching of the donor 
fluorophore was also controlled for with a titration series containing labeled donor 
and unlabeled substrate. No significant contribution to the overall FRET signal 
due to an increase in exposure or quenching of the donor molecule was 
observed in assays carried out with any PARP1 substrate. An additional 
correction was performed on images obtained using the donor emission 
wavelength band filter. Donor emission correction consisted of subtraction for 
acceptor fluorophore signal in the ‘acceptor-only’ wells from the FRET titration. 
This contribution can be significant due to the low [donor] and is necessary for 
the accurate calculation of dissociation constants. Final plotted values were 
corrected for acceptor signal contribution (calculated from ‘acceptor-only’ 
titration) and donor signal contribution (from ‘donor-only’ wells) according to the 





Figure 5- Interaction between PARP1 and DNA generates a FRET signal 
through energy transfer from donor to acceptor fluorophores. (A) Excitation 
(dashed line) and emission (solid line) of the Alexa488 fluorophore (in green) 
and Cy5 fluorophore (in blue). Grey bar is representative of the emission band 
filter applied in FRET experiments using the Typhoon imager. Graph adapted from 
Invitrogen website (B) Fluorescent image of PARP1-DNA FRET assay produced 
by Typhoon scanner. Rows each image represent an acceptor-only control (1) 
and the FRET reaction with titrated acceptor and fixed [donor] (2). Each reaction 
is imaged using three different excitation laser and emission band filter 
combinations optimized to obtain isolated signals from acceptor DNA (blue), 
protein donor (green), and FRET reaction (red). Corrected FRET overlay allows 
for visualization of increased production of energy transfer as DNA is titrated into 
a fixed [protein]. The final FRET signal utilized for generation of binding curves is 
normalized for donor and acceptor signal contribution. (C) Binding curve 
generated using prism software and corrected FRET data from images produced 
by Typhoon scanner, such as that observed in (B), of PARP1-486 binding affinity to 





where FRETc is final corrected FRET signal, FRET is total signal obtained using 
FRET excitation and emission settings, and Dc and Ac are percent contribution 
to overall FRET signal due to donor (D) and acceptor (A). 
 
Mode of PARP1 DNA interaction  
In addition to the Parp1-486 E. coli expression system, other members in the Luger 
lab generated a system utilizing insect cell expression and purification of full-
length PARP1. Both expression systems yield an efficient quantity of pure 
protein. The full-length PARP1 product, however, is much more susceptible to 
degradation and loss due to non-specific interactions with dialysis tubing and 
concentrators. The Parp1-486 product is very stable and exhibits a lesser degree 
of non-specific interactions. It was hypothesized that truncated Parp1-486 protein 
would suffice for DNA-binding studies, as the domains incorporated comprise the 
DNA-binding domain of PARP1. The DNA-binding domain of PARP1 has been 
found to be necessary and sufficient in PARP1 DNA-damage recognition and 
binding. As such, Parp1-486 expressed from E. coli was used predominantly in 
PARP1-DNA interaction characterization.  
 
In order to confirm the hypothesis that the Parp1-486 mutant would suffice for 
binding studies, a comparison between Parp1-486 and full-length PARP1’s affinity 
to blunt-ended DNA was performed. Full-length PARP1 and Parp1-486 affinity to 
blunt-ended DNA was measured at 200 mM NaCl. Parp1-486 displayed an affinity 
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of ~ 45 nM, whereas full-length PARP1 bound approximately two-fold tighter with 
an affinity of ~ 26 nM (Figure 6). Previous studies have shown PARP1 loses 
specificity for DNA upon the loss of the Zn1 domain, and ΔZn2 constructs display 
greatly reduced affinity to DNA [9]. This indicates that the WGR-Cat region of 
PARP1 (487-1014) most likely only contributes in a stabilizing manner and is 
complementary to the Parp1-486-DNA interaction. This would account for the 
approximate two-fold increase in binding affinity and indicate that the Parp1-486 
construct is sufficient in relative DNA-binding characterization studies.      
  
While obtaining the Parp1-486 affinity to blunt-ended DNA, an interesting 
discrepancy in Parp1-486 affinity to the DNA substrate was observed. After further 
analysis it was noted that the only variable altered was the concentration of NaCl 
in the reaction buffer. Data previously published by our lab suggested a binding 
affinity of Parp1-486 to blunt DNA of approximately 300 nM (fluorescent quenching 
experiments performed at 300 mM NaCl) [8]. In order to further explore an 
electrostatic dependence on binding, FRET-based binding assays were 
performed utilizing reaction buffer containing an [NaCl] gradient ranging from 175 
mM NaCl to 250 mM NaCl (Figure 7B). A log(Kd) vs log[NaCl] plot yielded a 
linear electrostatic dependence for the Parp1-486 to blunt-ended DNA interaction 
(Figure 7A). A slope of ~ 6 was generated from the linear fit of the log(Kd) vs 





Figure 6- Full-length PARP1 binds with higher affinity to DNA damage 
models than the truncated PARP1-486 construct. (A)  Table displaying full-
length PARP1 and PARP1-486 affinities to blunt-ended DNA. Dissociation 
constants generated are the product of FRET assays performed with at least 
two biological replicates. Error bars are representative of one standard 
deviation. (B) Bar graph representative of observed affinities presented in the 
above table. Full-length PARP1 (dark blue) binds approximately 2-fold tighter 







Figure 7- PARP1 interaction with DNA is dependent on [NaCl]. (A) Log(Kd) 
vs Log[NaCl] plot of PARP1-486 affinity to blunt-ended DNA at 4 different [NaCl]. 
PARP1-486 affinities were generated using the FRET-based assay after analysis 
of data produced by the Typhoon imager. Data points displayed are 
representative of at least two biological replicates and error bars were produced 
by a single standard deviation. A linear fit produces a slope of ~ 6, indicating the 
presence of 6 ion pairs at the PARP1-486-DNA interface. (B) Table showing each 






interface. Similar electrostatic dependence was also observed when assaying 
additional DNA constructs (data not shown), indicating that the dependence is 
not unique to the blunt-ended DNA.    
 
PARP1 preference for specific DNA architecture  
To date, the PARP1-DNA interaction has not been shown to exhibit any DNA 
sequence specificity [1, 2]. It has been long known that PARP1 binds in vitro and 
in vivo to sites of DNA-damage, as well as to various unique DNA conformations 
void of DNA-damage, such as hairpin loops and cruciform DNA [1, 2]. In the 
literature, reliable data outlining the binding affinity of PARP1 to its proposed 
DNA partners is limited. Previous studies in our lab demonstrated that Parp1-486 
displays similar affinity to overhang and nicked DNA, which is approximately 
three times tighter than to blunt DNA (reaction performed with 300 mM NaCl) [8].  
 
The developed in-solution FRET-based assay was first utilized to confirm 
previous data on Parp1-486 affinity to blunt, nicked and overhang DNA. The blunt-
ended and nicked DNA’s were not altered from previous studies in the Luger lab 
[8]. A slight alteration to the overhang DNA was performed to better ensure the 
model was representative of a true overhang region. Rather than truncating one 
of the strands of the DNA double-helix to produce a single overhang, strands of 
30 bps each were annealed in a fashion that yields two overhangs per DNA 




Figure 8- PARP1 binds various DNA substrates. (A) Graphic 
representations of DNA constructs used in FRET binding assays. From left to 
right, models are of blunt-ended DNA, 5’-overhang DNA (top row), DNA with 
an internal ‘nick’ and DNA containing a central AATT sequence substitution 
yielding increased strand flexibility (bottom row). DNA sequences are 
indicated below each corresponding model. Conserved sequences are 
displayed in black and significant changes to DNA strands are indicated in red.  
(B) Dark field microscopy displaying intrinsic flexibility of 139bp DNA which 
contains a central nick at base pair 69 in the absence of PARP1 (left) and with 
PARP1 bound (arrow in right panel) as adapted from de Murcia et al., Mol 





blunt-ended DNA and the overhang DNA (~45 nM), while exhibiting a binding 
affinity that was 3-5 times tighter to the nicked DNA ( ~10 nM) (Figure 9). In our 
lab’s previous publication describing PARP1 affinities, the blunt-ended DNA was 
found to be a weaker binding substrate than both the 3’-overhang DNA and the 
nicked DNA, which PARP1 bound with similar affinity [8]. The results from the 
FRET-based assay differ from the previous publication in indicating that PARP1 
binds blunt-ended DNA and 3’-overhang DNA with relatively the same affinity 
while binding nicked DNA ~ five-fold tighter. A similar affinity displayed by PARP1 
for 3’-overhang DNA and blunt-ended DNA, which contrasts to its affinity to 
nicked DNA, is logical. This is due to the closer resemblance of 3’-overhang DNA 
and blunt-ended DNA to DSBs repaired through HR and NHEJ, compared to 
nicked DNA’s relation to SSBs repaired via the BER pathway. It is possible non-
specific interactions with reaction vessel surfaces had a more pronounced effect 
on past experiments than previously thought. Any variation in [Parp1-486] due to 
non-specific interactions would lead to a shift in the affinity curve, as previous 
experiments used Parp1-486 as the titrant, which is opposite of the FRET-based 
method utilized here. Additionally, the alteration in the 3’-overhang construct may 







Figure 9 - Thermodynamic representation of Parp1-486 interaction with various DNA-damage constructs. (A) 
Overlay of Parp1-486-DNA-damage binding curves generated from FRET data obtained by the Typhoon imager. 
Parp1-486 binds with highest affinity to 30mer DNA sequences containing a single, centrally located nick (gold) and 
DNA with induced flexibility due to an AATT-sequence insert (purple). Parp1-486 binds more weakly to DNA modeled 
after DSBs containing blunt ends (blue) and 3’-overhangs (green). Each data point is representative of assays 
performed in biological replicate and error bars were generated using single standard deviation (B) Bar graph 
comparing observed Kd’s for nicked DNA (~11nM), DNA containing an AATT insert (~17nM), blunt ended DNA 
(~45nM) and 3’-overhang DNA (~47nM). Increased flexibility upon AATT insertion into the center of the blunt DNA 
produces a three to five-fold increase in Parp1-486 affinity to the DNA substrate.  
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DNA constructs composed of various sequences were generated to assess the 
effect of sequence alteration in PARP1’s affinity to blunt-ended DNA. 
Unexpectedly, it was observed that Parp1-486 bound to a 30mer sequence 
containing a stretch of A-T base pairs with an affinity considerably tighter than 
what was observed with the previously used 30mer blunt sequence (Figure 9B). 
 
No previous data has been presented indicating sequence specificity in PARP1-
DNA interactions. Due to this we evaluated other factors that may have 
contributed to the increase in affinity observed. Tracts of 4 or more A:T base 
pairs have been shown to induce flexibility in DNA sequences [56] (Figure 8B). 
For example, poly(A:T) tracts are incorporated into the 601 nucleosome-
positioning sequence [57] due to past evidence displaying that nucleosomes tend 
to form on sequences with an increased degree of flexibility [53]. Past literature 
has also proposed a similar propensity for flexible DNA by PARP1 [58-60]. We 
explored the affinity of Parp1-486 for DNA exhibiting a higher degree of flexibility 
through the incorporation of the same AATT sequence into the center of the 
previously tested 30mer blunt-ended DNA. Parp1-486 affinity to blunt-ended DNA 
with an imbedded AATT sequence was similar to that of the nicked DNA 
(~15nM), indicating Parp1-486 binds preferably to DNAs with increased flexibility 
(Figure 9). A proportional increase in affinity to blunt-ended DNA containing an 
AATT insert with full-length PARP1 was also observed (data not shown), 
indicating that the WGR-Cat region does not contribute to the discrepancy in 




PARP1 and H1 have been shown to compete for nucleosome binding at 
promoter regions of transcriptionally active or repressed genes [32]. This 
indicates close proximity of PARP1 and H1 binding sites along chromatin. The 
Kraus group demonstrated that portions of the DNA-binding region and catalytic 
domain of PARP1 are necessary and sufficient for nucleosome array compaction 
[30]. These results suggest a characteristic difference between PARP1’s mode of 
binding to DNA-damage models (in which the DNA-binding region is sufficient for 
proper interaction) and nucleosome complexes. To ensure binding affinity data 
generated on PARP1-nucleosome interactions was representative of the true 
biological mechanism, fluorescently labeled full-length PARP1 was utilized.  
 
To investigate the PARP1 mode of interaction with nucleosomes, 
mononucleosomes containing varying DNA linker lengths were prepared. 
Mononucleosomes were assembled using DNA sequences with the 601 
nucleosome positioning sequence [57], with lengths of 147bp, 165bp and 207bp 
(Figure 10A). 147bp of DNA make contact with the histone octamer forming the 
nucleosome core particle (NCP) [26]. Additional DNA lengths utilized in 
mononucleosome formation will generate nucleosomes with DNA linker arms of 






Figure 10- Full-length PARP1 binds tightly to nucleosomes containing 
linker DNA. (A) Models of mononucleosomes engineered with DNA mimicking 
regions of the 601 nucleosome-positioning sequence [51]. Mononucleosomes 
generated using 207bp (blue) and 165bp (gold) of DNA yield linker arms of ~ 
30bp and ~10bp, respectively. Mononucleosomes produced using 147bp of 
DNA (green) do not have a sufficient length of DNA to produce linker arms. (B) 
Full-length PARP1 binds with an affinity of ~1nM to 165bp mononucleosomes 
(gold) and 207bp mononucleosomes (blue). In comparison, full-length PARP1 
binds very weakly to 147bp mononucleosomes (green), which do not contain 
enough DNA to establish linker arms beyond the NCP. Dissociation constants 
were generated through measurement of increasing FRET throughout a 
titration of PARP1 substrate into constant [full-length PARP1]. Data points are 




asymmetrical placement preference of the histone octamer (Figure 10A)). The 
integrity of mononucleosomes and absence of significant amounts of free DNA 
was confirmed by native gel electrophoresis. 
 
Stoichiometry of the PARP1-mononucleosome complexes was measured by 
Nick Clark and Dr. Uma Muthurajan of the Luger lab. Full-length PARP1 and 
Parp1-486 were able to bind and shift the 147, 165, and 207 bp mononucleosomes 
in EMSA experiments with a 1:1 binding ratio. The interaction observed in EMSA 
between PARP1 and the 147bp mononucleosomes was counter to our initial 
hypothesis that PARP1 interacts primarily with the linker DNA of 
mononucleosomes. To confirm the validity of the EMSA results, analytic 
ultracentrifugation (AUC) was performed on full-length PARP1 and 
mononucleosomes independent of each other and in complex. AUC clearly 
demonstrates an interaction of 1:1 stoichiometric ratio between full-length PARP1 
and 165bp mononucleosomes, as well as with 207bp mononucleosomes. The 
full-length PARP1-147bp mononucleosome complex, however, was not stable in 
AUC. The PARP1-147bp mononucleosome complex observed in EMSA is 
possibly due to forced interaction as a result of spacial restriction by the gel 
pores. AUC stoichiometry results were verified using size-exclusion 
chromatography coupled with multiangle light scattering (SEC-MALS).  All 
stoichiometry experiments were repeated with Parp1-486 and yielded identical 
results, indicating that the DNA-binding region of PARP1 is able to bind 
mononucleosomes independently of the WGR and catalytic domain.  
51 
 
In an attempt to ascertain characteristic differences in binding between Parp1-486 
and full-length PARP1, which would assist in a rationalization of the chromatin 
compaction data procured by the Kraus group, affinities of Parp1-486 and full-
length PARP1 to the mononucleosome models were obtained. Reactions 
performed in the microplate FRET-based assay at 200 mM NaCl produced an 
approximate affinity of 1nM for the full-length PARP1 interaction with both 165bp 
and 207bp mononucleosomes (Figure 10B). Due to full-length PARP1’s high 
affinity to the 165bp and 207bp mononucleosome complexes, only an 
approximate dissociation constant was obtained due to an inability to maintain 
the [donor] (full-length PARP1) 5-10-fold below the final Kd. Assays performed 
with varying donor concentrations (at least 2x below the predicted Kd) all 
produced affinities of approximately 1 nM, providing credence to the ascertained 
full-length PARP1 affinity to 165bp and 207bp mononucleosomes. FRET 
reactions containing full-length PARP1 and 147bp mononucleosomes did not 
produce a curve containing a plateau at high concentrations of acceptor, 
indicating a very low affinity for full-length PARP1 to 147bp mononucleosomes 
(Figure 10B).  
 
Parp1-486’s affinities to 147bp and 207bp mononucleosomes were then obtained 
via FRET microplate reactions. Parp1-486 displayed an extremely weak affinity to 
147bp mononucleosomes, with FRET measurements lacking an upper plateau in 
a manner similar to what was observed with full-length PARP1 (Figure 10). 
Additionally, compared to full-length PARP1, Parp1-486 displayed a relatively weak 
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affinity to 207bp mononucleosomes (~95 nM) (Figure 11). Parp1-486’s affinity to 
mononucleosomes containing linker arms is approximately 100-fold weaker than 
full-length PARP1 (Figure 11), as compared to a two-fold difference observed in 
binding affinities to DNA-damage models (Figure 6). The difference in relative 
binding affinities indicates different modes of interaction for full-length and Parp1-









Figure 11- Full-length PARP11 binds with an affinity 100x tighter than 
Parp1-486 to 207bp mononucleosomes. (A) Curves fit to data points obtained 
from FRET reactions imaged by the Typhoon scanner. Reactions were 
performed in biological replicate for reactions comprised of titrated substrate 
(0.1 nM-400 nM) and constant [PARP1] (0.5 nM in full-length PARP1 assays; 2 
nM in PARP1-486 assays). Error bars represent a single standard deviation. (B) 
Table of affinities generated from the above FRET data (A). Due to limitations of 
the FRET system an exact dissociation constant for full-length PARP1 could not 
be obtained, but FRET assays carried out with various [probe] displayed Kd’s 
within 0.6 nM to 1.5 nM. In comparison, PARP1-486 binds much more weakly 







Development of a high-throughput binding assay 
The fluorescence quenching technique previously employed to obtain binding 
affinity data of the PARP1-DNA interaction was inefficient. This was due to 
issues with instrumentation and non-specific interactions between the protein and 
plate wells. I developed a FRET-based in-solution assay in place of fluorescent 
quenching. FRET utilizes the transfer of energy from the emission of a donor 
fluorophore to a nearby acceptor fluorophore. As such, FRET is a powerful tool 
when investigating proteins, such as PARP1, which displays a propensity to non-
specifically interact with surfaces. In the assay developed here, non-specific 
interactions of PARP1 are negligible as a FRET signal is only produced upon 
protein-DNA interaction. Additionally, any emission from non-specifically 
interacting PARP1 can be corrected for in the overall FRET signal. It is important 
to note, however, that FRET is only effective if proper controls are employed to 





The developed FRET-based assay exhibits high experimental efficiency due to 
the incorporation of microplates and the Typhoon imager. Microplates containing 
384 wells allow for high efficiency, as up to four assays (23-point titration 
reactions in quadruplicate) can be performed on a single plate, all of which can 
be simultaneously quantified. Furthermore, consistency between assays is 
achieved through ensuring a consistent reaction environment in the microplate 
wells due to the employment of the hydrophobic coating (2% 1,6-
dichlorooctamethyl-tetrasiloxane). Our FRET assay, coupled with the Typhoon 
imager, is highly sensitive. High sensitivity also allows for the use of low amounts 
of labeled donor (protein), making it possible to test a multitude of binding 
substrates without consuming large amounts of labeled protein. Because of 
these advantages, the FRET-based assay developed here is being incorporated 
within our lab to multiple other protein-binding systems, such as in the 
characterization of H1-nucleosome, MeCP2-nucleosome and Swc2-DNA 
interactions.  
 
Mode of PARP1 DNA-binding 
Recently, crystal structures of the first two Zn fingers of PARP1 in complex with 
blunt-end DNA was solved [9]. The crystal structure revealed that each Zn finger 
contains a hydrophobic loop that interacts via base stacking with exposed base 
pairs at the ends of the DNA, along with a ‘phosphate backbone grip’ loop that 
provides additional stabilization of the complex through contacts with the 
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phosphodiester backbone [9]. A log(Kd) vs log[NaCl] plot of Parp1-486’s affinity to 
blunt-ended DNA indicates six ions pairs located at the Parp1-486-DNA interface. 
This correlates well with the Zn finger-DNA crystal structures, where three 
positively charged residues are identified in the phosphate backbone grip of each 
Zn finger. Thus, our results concur with the Pascal group in identifying the 
phosphate backbone grip as providing electrostatic stabilization to the PARP1-
DNA complex.  
 
The domains excluded from the Parp1-486 construct in the WGR-Cat region also 
contain a highly basic net charge. The two-fold increase in binding affinity 
exhibited by full-length PARP1 as compared to Parp1-486 is most likely a result of 
the additional positive charge contained on the surface of the WGR-Cat region. 
Thus, an increase in [NaCl] could further diminish stabilization of PARP1 
interaction with DNA substrates through neutralization of the additional positive 
charge located in the WGR-Cat region. The significant variabilition in DNA-
binding affinity by PARP1 with NaCl concentration could be explained by the 
dependence on electrostatic stabilization of the PARP1-DNA complex by DNA 






PARP1 affinity is affected by specific DNA architecture 
Binding data in the literature fails to establish a systematic approach to obtain 
PARP1’s affinity to various DNA substrates. A commonly cited publication by D’ 
Silva et al. derives dissociation constants for PARP1 from Lineweaver-Burk plots 
of PARP1 activity [61]. Added precaution must be exhibited in PARP1-DNA-
binding studies due to PARP1’s conformational change upon interaction with 
DNA. Using traditional enzyme kinetics to determine specific binding affinities in 
a multistep reaction, such as with PARP1 binding DNA, can be very difficult. As 
such, binding affinities obtained for PARP1 using this method are not as reliable 
as direct analysis of binding, such as in the FRET binding assay. As a result, 
they produce data suggesting PARP1 prefers DSB’s over SSB’s, which is 
contrary to what we observe using FRET.  
 
 Additionally, it is common practice to utilize surface plasmon resonance (SPR) 
when researching PARP1 binding properties. Although it is possible to 
characterize the PARP1-DNA complex utilizing SPR, a representation of native 
conditions in the cell are better achieved using the FRET-based assay. This is 
due to the FRET assay’s employment of in-solution reactions. Furthermore, 
because a FRET signal is only produced upon PARP1-DNA interaction, any 
contribution from PARP1 binding to surfaces will not be detected, which is a 




Fluorescent quenching of DNA and fluorescence anisotropy have proven 
successful in characterization of the PARP1-DNA complex [8, 9]. Due to 
inefficiencies with methods and equipment, however, neither method provides a 
high-throughput system in which comparison of PARP1’s affinity to different 
damage models can be performed. 
 
The FRET binding assay I developed has the advantage of being unaffected by 
PARP1 non-specifically interacting with surfaces, because it directly analyzes 
PARP1 binding to DNA. Through utilization of our FRET-binding assay I was able 
to map PARP1 affinities to multiple DNA substrates. Of the DNA models we 
characterized, the blunt-ended DNA and overhang DNA best represent DSB’s, 
whereas nicked DNA better mimics SSB sites found within the cell. Results of the 
FRET-based assay indicate that the DNA-binding domain of PARP1 prefers the 
nicked DNA, binding 3-5 times more tightly than blunt and overhang DNA.  
 
Additionally, PARP1 displayed similar affinity to blunt-ended DNA containing a 
centrally located AATT sequence and nicked DNA. Dark-field microscopy and 
AFM data displays a visible bend in DNA strands containing a central incision in 
the phosphodiester backbone [60]. DNA sequences containing spans of four or 
more A-T base pairs have also been shown to have an induced bend and are  
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often used in nucleosome positioning sequences due to their flexible nature [56]. 
Thus, the similar affinity of PARP1 for nicked DNA and DNA containing an AATT 
insert appears to be due to the increased flexibility exhibited by both constructs.  
 
Crystal structures of the first two Zn fingers of PARP1 independently in complex 
with blunt-ended DNA indicate that a single loop found in both Zn finger motifs 
contains two hydrophobic residues that interact with DNA base pairs exposed at 
the blunt ends through base stacking [9]. It is likely that PARP1’s increase in 
affinity for DNA substrates displaying distortion in the form of a bend is due to an 
increase in accessibility of the Zn finger hydrophobic loops to DNA. Furthermore, 
due to the presence of nucleotides adjacent to both sides of PARP1’s 
hydrophobic loop, additional base stacking may be achieved in the nicked and 




PARP1 requires linker DNA for interaction with nucleosomes 
PARP1 has been shown to play variable roles in gene expression via interactions 
with nucleosomes in a catalytically active and inactive manner [30, 31, 33].  
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The Kraus group showed that the DNA-binding region of PARP1 was necessary 
and sufficient for nucleosome binding, but that compaction of nucleosome arrays 
requires portions of the catalytic domain [30]. 
 
Here we further explore the PARP1-nucleosome complex through the 
observation of PARP1 binding affinity to mononucleosomes containing varied 
linker arm lengths. EMSA suggests that PARP1 has the ability to bind147bp, 
165bp, and 207bp mononucleosomes through visualization of a band shift. AUC 
and SEC-MALS, however, indicate that full-length PARP1 and Parp1-486 do not 
interact with 147bp mononucleosomes, while binding with a stoichiometry of 1:1 
to 165bp and 207bp mononucleosomes.  This demonstrates the unreliability of 
EMSA shifts in the indication of true interaction. Additionally, analysis of FRET-
based studies indicates very weak binding of both full-length PARP1 and Parp1-486 
to 147bp mononucleosomes, implicating the necessity of linker DNA for PARP1-
nucleosome interaction.  
 
My results suggest that PARP1 binds with higher affinity to flexible DNA rather 
than blunt-ended DNA. Additionally, the PARP1 Zn fingers appear to interact with 
exposed base pairs through based stacking hydrophobic loops [9]. DNA wrapped 
around the histone octamer displays both of these characteristics. This poses the 
question, why doesn’t PARP1 interact with DNA making contact with the histone 
octamer? To answer this question the orientation of PARP1 binding must be 
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understood. The PARP1 Zn fingers are connected by a flexible loop [1], providing 
them with multiple potential conformations in which they can interact with DNA. A 
binding mode in which the Zn fingers bound in series to DNA would likely permit 
PARP1 binding to DNA surrounding the histone octamer (Figure 12A). PARP1 
binds to DNA with a footprint of 14 bps [53]. As such, if PARP1 bound in series to 
DNA surrounding the histone octamer, a potential binding ratio of ~ 10 PARP1 
molecules per nucleosome would be observed. This is not the case, however, in 
our stoichiometry experiments, which display a 1:1 binding ratio. In addition, 
affinity experiments display very weak binding is observed by both full-length 
PARP1 and Parp1-486 to mononucleosomes not containing DNA linker arms. 
 
 Alternatively, the Zn fingers may be interacting with DNA in a more offset, or 
‘clamped’ conformation (Figure 12A). If the PARP1 Zn fingers bound with a 
clamped orientation to DNA any additional protein contacts made with the DNA 
substrate, such as with the histone octamer, would sterically inhibit PARP1 
interaction. This models correlates with what was described with our results and 
is further supported by published crystallographic data [9].        
 
A binding stoichiometry of 1:1 to mononucleosomes containing DNA linker arms 
is also interesting. PARP1 binds to blunt-ended DNA as short as 7bps [53] and 
as such, contains the ability to bind both DNA linker arms of mononucleosomes. 






Figure 12- PARP1 binds to mononucleosomes containing DNA linker 
arms with a 1:1 stoichiometry. (A) PARP1 does not interact with DNA 
surrounding the histone octamer despite indications that it prefers DNA with 
exposed base pairs. Taking PARP1’s binding preference and the flexible loop 
connecting the two Zn fingers (green and gold) into account two potential 
binding orientations are proposed. Zn1 and Zn2 may bind to DNA (blue) in 
series (left) or in a staggered ‘clamp’ orientation (right). Our results imply the 
clamped conformation appears more likely as contacts made by the histones 
with DNA would better restrict the PARP1 Zn fingers from binding in this 
manner. (B) PARP1 binds to mononucleosomes with DNA linker arms (blue) 
in a 1:1 stoichiometry, indicating either blocking or occupation of the second 
linker arm. This may either occur by the WGR-Cat region of PARP1 blocking 
interaction by a second PARP1 molecule (left) or by occupancy of both DNA 
linker arms by PARP1 as it bridges the two blunt-ended strands (right).   
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mononucleosomes suggests steric blocking or occupancy of the DNA linker arm. 
Blocking may occur due to the orientation of the initial PARP1 molecule bound to 
the other DNA linker arm (Figure 12B). Data has indicated that PARP1 binds with 
a specific orientation when bound to DNA [55]. The WGR-Cat region of PARP1 
would likely inhibit binding of a second PARP1 molecule if orientated away from 
the NCP. A 1:1 stoichiometry is also observed, however, with Parp1-486 which 
does not contain the large WGR-Cat region. It is possible that unbound Zn3 and 
BRCT domains contribute to steric hindrance of the second DNA linker arm, but 
this would likely be to a much lesser extent than the full-length protein. 
Restriction of the second DNA linker arm may also occur through bridging of the 
two linker arms by PARP1 (Figure 12B). Due to multiple DNA binding sites, 
PARP1 has the potential to interact with multiple DNA substrates in tandem. This 
may account for the 1:1 binding ratio observed in AUC and SEC-MALS and could 
provide insight into the mechanism by which PARP1 acts to condense chromatin. 
 
Full-length PARP1 binds significantly more tightly to 207bp mononucleosomes 
than Parp1-486  
Full-length PARP1 binds tighter to 165bp and 207bp mononucleosomes than to 
the DNA-damage models representing DSBs or flexible DNA. The linker arms of 
the 165bp and 207bp mononucleosomes contain a high A-T content (~ 65% of 
entire linker sequence), with one linker arm containing a degree of flexibility due 
to a centrally located AATT stretch. The high A-T presence could itself be 
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responsible for the high affinity observed by full-length PARP1 to the engineered 
mononucleosomes. Parp1-486, however, binds to 207 mononucleosomes with 
weak affinity as compared to DNA-damage models containing AT repeats. This 
indicates that dependence on DNA linker arm flexibility or AT content for PARP1 
binding affinity is unlikely. 
 
This prompts the question, what property of full-length PARP1 that is not present 
in Parp1-486 gives it the capability to bind with such high affinity to 
mononucleosome linker arms? The two-fold discrepancy between full-length 
PARP1 and Parp1-486 to DNA-damage constructs can be accounted for by the 
additional electrostatic stabilization contributed by the WGR-Cat region, which 
contains many exposed basic residues. An approximate 100-fold divergence 
between binding affinities, however, implies that while the DNA-binding region of 
PARP1 is necessary for nucleosome binding, it is not necessarily responsible for 
its strength of interaction. 
 
Full-length PARP1 may exhibit two potential binding mechanisms which take into 
account binding affinity dependent on presence of the WGR-Cat region. (1) The 
WGR-Cat region may contribute additional stabilization of the interaction. This 
would be due to additional electrostatic contacts made due to an increased 
proximity to additional negatively charged DNA, or through specific contacts 
made by the WGR or catalytic domain with the nucleosome as is suggested in 
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the literature [30, 55]. Preliminary EMSA data shows, however, that truncation 
constructs containing only the WGR-Cat region do not interact with 147bp and 
165bp mononucleosomes (data not shown). (2) It has been reported that PARP1 
undergoes conformational change upon 30mer DNA-binding [9].  The presence 
of the WGR-Cat region at the C-terminus of PARP1 may allow for a more 
complete conformational change that cannot occur with Parp1-486. This 
conformational change would potentially lock the protein in a bound state, 
increasing the affinity of interaction. Additionally, induction of a locked 
conformation would limit the PARP1 dissociation rate.  
 
This may act as a switch between PARP1’s chromatin compaction and gene 
expression functions. After binding to chromatin, the PARP1-nucleosome 
interaction would remain stable until activation of PARP1. PARP1 would then 
promote chromatin relaxation while still bound to nucleosomes, allowing 
transcription to occur. Then, once a threshold of auto-modification by PARP1 










SUMMARY AND FUTURE DIRECTIONS 
 
PARP1 and DNA-damage recognition 
PARP1 maintains many functions within the cells through interactions with many 
different DNA substrates. Due to its prevalence in many cellular processes 
PARP1 has been targeted in drug therapies to treat medical conditions ranging 
from inflammation regulation to cancer. In order to better understand regulation 
of PARP1 function in the cell, it is necessary to analyze PARP1’s interaction with 
DNA substrates. The most studied and possibly most significant mode of 
regulation exists in PARP1 recognition of DNA. It is possible this form of 
regulation occurs through discrepancies in binding affinity by PARP1 to DNA 
substrates during its various cellular functions. PARP1 interacts with DNA-
damage models and nucleosomes, in what appears to be two different binding 
mechanisms.  
 
I have developed a high-throughput in vitro binding assay to characterize 
PARP1’s interaction with sites of DNA-damage and mononucleosomes. Our 
FRET-based assay has proved to be highly reproducible as well as acutely  
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sensitive. In addition, the FRET assay can be easily manipulated to incorporate 
the different interactions of PARP1, or any other fluorescently modifiable protein, 
forms with different cellular substrates.   
    
Our results suggest a binding preference exhibited by PARP1 for DNA 
sequences permitting an increased accessibility to base pairs, such as DNA 
containing an internal nick or increased flexibility through the introduction of AT 
repeats. Binding affinity data presented here and structural data recently 
published on interactions by each Zn finger to blunt-ended DNA, convey a 
mechanism in which PARP1 recognizes sites of DNA-damage. PARP1 appears 
to primarily interact with DNA through hydrophobic loops present in the two Zn 
fingers. This interaction is stabilized through electrostatic interactions by highly 
basic regions located throughout the protein. 
 
Additionally, results presented here suggest that Parp1-486, which contains the 
DNA-binding domain of PARP1, binds slightly more weakly to DNA constructs 
mimicking DNA-damage than does full-length PARP1. This may be due to a 
significant electrostatic dependence on PARP1 binding affinity to DNA, as the 
full-length protein contains additional basic residues that could assist in PARP1-




These results have provided a quality start in the overall characterization of 
PARP1’s interactions with non-nucleosomal DNA in the cell. Further studies 
carried out utilizing the FRET assay must be performed on PARP1’s other known 
DNA partners to obtain a more complete understanding of its binding 
mechanism. Such substrates include DNA with non-canonical B-form 
architecture, hairpin loops and 4-way junction DNA (aka Holliday junction DNA). 
In addition, more insight into the role of PARP1 in transcription could be 
investigated. This would be accomplished through analysis of PARP1 affinity to 
promoter and insulator regions that it has been found to associate with while 
functioning in transcriptional regulation. 
 
 
PARP1 and chromatin dynamics 
PARP1 has also been identified as a major contributor to transcriptional 
regulation through modulation of chromosomal dynamics [1, 2, 32, 35, 38]. 
PARP1 functions to compact chromatin when catalytically inactive, and can 
promote chromatin relaxation through PARylation of core histones once 
activated. As a means to understand PARP1’s variable function in chromatin 





It was observed that full-length PARP1 and Parp1-486 require the presence of 
DNA linker arms in order to associate strongly with mononucleosomes. This was 
demonstrated by the lack of interaction of both constructs with mononucleosome 
constructs engineered with only 147 bps of DNA in AUC, SEC-MALS and the 
FRET binding assay. Full-length PARP1 and Parp1-486 were found to bind with a 
1:1 stoichiometry to 165bp and 207bp mononucleosomes. Additionally, full-length 
PARP1 was found to bind considerably more tightly to 207bp mononucleosomes 
than Parp1-486, suggesting a PARP1 binding mechanism to mononucleosomes 
that does not parallel what is observed with its binding to sites of DNA-damage.  
 
Two mechanisms were proposed in which the WGR-Cat region of PARP1 plays 
a significant role in establishing high affinity to mononucleosomes containing 
DNA linker arms. First, full-length PARP1 binding to nucleosomes may be 
stabilized through additional contacts made by the WGR or catalytic domain to 
the nucleosome. Such contacts may either be additional electrostatic stabilization 
or direct interaction with the histone octamer. Alternatively, the presence of the 
WGR-Cat region may be necessary to produce a more complete conformational 
change than what is seen with Parp1-486 upon binding to nucleosomes. 
Preliminary result suggest the latter is more likely, as truncation constructs 




In order to confirm this mechanism, more tests must be performed on the affinity 
of PARP1 to mononucleosomes. Sequentially decreasing the lengths of DNA 
linker arms would allow determination of the minimum amount of DNA needed for 
PARP1 to bind mononucleosomes. Additionally, mononucleosomes produced 
containing DNA linker arms without DNA ends could be employed to test 
PARP1s dependence on blunt ends for binding. This would be performed using 
either nucleosomes formed on plasmid DNA, or mononucleosomes containing 
biotinylated ends that could be joined together by streptavidin. Additionally, 
compaction of DNA linker arms can be assessed utilizing our FRET assay and 
the transfer of the donor FRET label to the linker DNA. Compaction would then 
be observed through monitoring FRET levels upon introduction of unlabeled 
PARP1.   
 
A potential alteration in binding affinity by PARP1 to mononucleosomes with 
introduced sites of damage, such as nicks or lesions, could also be investigated. 
In order to test this, binding assays with full-length PARP1 and Parp1-486 to 147bp 
mononucleosomes after introduction of damage regions would be performed. 
Sites of damage would be induced by hydroxyl radical exposure or induction 
through PCR of specific sites of damage into the 147bp DNA prior to 
mononucleosome assembly. In addition, PARP1 binding to wild-type nucleosome 
arrays and damage-incorporated nucleosome arrays could be analyzed by FRET  
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and AFM. These results would provide information regarding the events that 
unfold as PARP1 recognizes sites of DNA-damage after associating with 
nucleosomes.  
 
Additional PARP1 research in development 
Additional experiments presently in progress will also provide further insight into 
the PARP1 binding mechanism. Systems currently undergoing development 
focus on PARP1 activity upon substrate binding and structural characterization of 
the full-length PARP1-DNA complex through x-ray crystallography and small 
angle x-ray/neutron scattering. Activity analysis of PARP1 upon binding to 
different substrates is essential to complete characterization of PARP1’s 
interactions within the cell. We have formulated a hypothesis in which PARP1 
recognizes and binds to DNA substrates, producing a conformational change that 
generates variable activation corresponding to PARP1’s affinity to the given 
substrate. Regulation of catalytic activity through a conformation change induced 
upon substrate binding would account for the PARP1’s ability to distinguish 
between its many functions.   
 
PARP1 is involved in cellular pathways ranging from mitotic spindle apparatus 
formation to cell-death signaling [1]. Due to its many roles in the cell, a clear 
indication of how PARP1 regulates its function has been difficult to obtain. Data 
presented here provide a foundation for a further research on the PARP1 binding 
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mechanism. Detailed comparison of PARP1 affinity to its various DNA-binding 
partners, along with additional PARP1 activation and structural data will produce 
a more unified understanding of how PARP1 maintains variable functions 
throughout the cell. 
 
From a larger scope, a more unified understanding of PARP1 function in the cell 
is necessary as multiple cancer treatments target PARP1 as a method in 
chemotherapy. Such methods incorporate drugs acting to inhibit PARP1 function, 
as PARP1 inhibition leads to DNA-damage propagation. DNA-damage 
propagation in cells, including cancer cells, frequently leads to cell-death. Such 
drugs, however, fail to account for PARP1’s many other roles in the cell. PARP1 
inhibition has also been tied to the production of cancer cells, due to PARP1’s 
intricate and diverse involvement in cellular function. As such, PARP1 inhibition 
as a cancer treatment has the potential to give rise to secondary malignancies, 
making such cancer therapies ultimately limited, even if effective. Further 
investigation of a variable PARP1 binding mechanism may provide additional 
targets in selective inhibition of PARP1. Selective inhibition would add power to 
cancer therapies targeting PARP1 and reduce the potential for secondary 
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